Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Jin Young, Sohn, Yujin, Lee, Su Hwan, Cho, Yunsuk, Hyun, Jong Hoon, Baek, Yae Jee, Jeong, Su Jin, Kim, Jung Ho, Ku, Nam Su, Yeom, Joon-Sup, Roh, Juhye, Ahn, Mi Young, Chin, Bum Sik, Kim, Young Sam, Lee, Hyukmin, Yong, Dongeun, Kim, Hyun Ok, Kim, Sinyoung, Choi, Jun Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152526/
https://www.ncbi.nlm.nih.gov/pubmed/32281317
http://dx.doi.org/10.3346/jkms.2020.35.e149
Descripción
Sumario:Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 not yet has established its treatment, but convalescent plasma has been expected to increase survival rates as in the case with other emerging viral infections. We describe two cases of COVID-19 treated with convalescent plasma infusion. Both patients presented severe pneumonia with acute respiratory distress syndrome and showed a favorable outcome after the use of convalescent plasma in addition to systemic corticosteroid. To our knowledge, this is the first report of the use of convalescent plasma therapy for COVID-19 in Korea.

Ejemplares similares